Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 35

1.

Protein tolerance to standard and high protein meals in patients with liver cirrhosis.

Campollo O, Sprengers D, Dam G, Vilstrup H, McIntyre N.

World J Hepatol. 2017 May 18;9(14):667-676. doi: 10.4254/wjh.v9.i14.667.

2.

Medical Care of the Patient With Compensated Cirrhosis.

Herrera JL, Rodríguez R.

Gastroenterol Hepatol (N Y). 2006 Feb;2(2):124-133.

3.

Hepatic encephalopathy: Ever closer to its big bang.

Souto PA, Marcotegui AR, Orbea L, Skerl J, Perazzo JC.

World J Gastroenterol. 2016 Nov 14;22(42):9251-9256. Review.

4.

Hepatic Encephalopathy: From the Pathogenesis to the New Treatments.

Cordoba J.

ISRN Hepatol. 2014 Jun 4;2014:236268. doi: 10.1155/2014/236268. eCollection 2014. Review.

5.

Nutrition therapy: Integral part of liver transplant care.

Anastácio LR, Davisson Correia MI.

World J Gastroenterol. 2016 Jan 28;22(4):1513-22. doi: 10.3748/wjg.v22.i4.1513. Review.

6.

Management options in decompensated cirrhosis.

Shah NL, Banaei YP, Hojnowski KL, Cornella SL.

Hepat Med. 2015 Jul 15;7:43-50. doi: 10.2147/HMER.S62463. eCollection 2015. Review.

7.

High Protein Diet and Huntington's Disease.

Chen CM, Lin YS, Wu YR, Chen P, Tsai FJ, Yang CL, Tsao YT, Chang W, Hsieh IS, Chern Y, Soong BW.

PLoS One. 2015 May 19;10(5):e0127654. doi: 10.1371/journal.pone.0127654. eCollection 2015.

8.

Hepatobiliary quiz-7 (2013).

Agrawal S, Dhiman RK.

J Clin Exp Hepatol. 2013 Sep;3(3):267-71. doi: 10.1016/j.jceh.2013.08.006. No abstract available.

9.

Nutritional status and liver transplantation.

Merli M, Giusto M, Giannelli V, Lucidi C, Riggio O.

J Clin Exp Hepatol. 2011 Dec;1(3):190-8. doi: 10.1016/S0973-6883(11)60237-5. Epub 2012 Jan 2.

10.

Pathogenesis, diagnosis, and treatment of hepatic encephalopathy.

Atluri DK, Prakash R, Mullen KD.

J Clin Exp Hepatol. 2011 Sep;1(2):77-86. doi: 10.1016/S0973-6883(11)60126-6. Epub 2011 Nov 9. Review.

11.

Managing complications in cirrhotic patients.

Peck-Radosavljevic M, Angeli P, Cordoba J, Farges O, Valla D.

United European Gastroenterol J. 2015 Feb;3(1):80-94. doi: 10.1177/2050640614560452.

12.

Protein restriction in hepatic encephalopathy is appropriate for selected patients: a point of view.

Nguyen DL, Morgan T.

Hepatol Int. 2014 Sep 1;8(2):447-51. doi: 10.1007/s12072-013-9497-1.

13.

Cirrhosis and its complications: evidence based treatment.

Nusrat S, Khan MS, Fazili J, Madhoun MF.

World J Gastroenterol. 2014 May 14;20(18):5442-60. doi: 10.3748/wjg.v20.i18.5442. Review.

14.

Malnutrition in liver cirrhosis:the influence of protein and sodium.

Eghtesad S, Poustchi H, Malekzadeh R.

Middle East J Dig Dis. 2013 Apr;5(2):65-75. Review.

15.

Management of hepatic encephalopathy in the hospital.

Leise MD, Poterucha JJ, Kamath PS, Kim WR.

Mayo Clin Proc. 2014 Feb;89(2):241-53. doi: 10.1016/j.mayocp.2013.11.009. Epub 2014 Jan 8. Review.

16.

Rifaximin in the treatment of hepatic encephalopathy.

Iadevaia MD, Prete AD, Cesaro C, Gaeta L, Zulli C, Loguercio C.

Hepat Med. 2011 Dec 22;3:109-17. doi: 10.2147/HMER.S11988. Review.

17.

Pathogenesis and management of alcoholic liver cirrhosis: a review.

Huang YW, Yang SS, Kao JH.

Hepat Med. 2011 Dec 24;3:1-11. doi: 10.2147/HMER.S10265. Review.

18.

Contributions of microdialysis to new alternative therapeutics for hepatic encephalopathy.

Rivera-Espinosa L, Floriano-Sánchez E, Pedraza-Chaverrí J, Coballase-Urrutia E, Sampieri AI, Ortega-Cuellar D, Cárdenas-Rodríguez N, Carmona-Aparicio L.

Int J Mol Sci. 2013 Aug 5;14(8):16184-206. doi: 10.3390/ijms140816184. Review.

19.

Alcoholic hepatitis: current challenges and future directions.

Singal AK, Kamath PS, Gores GJ, Shah VH.

Clin Gastroenterol Hepatol. 2014 Apr;12(4):555-64; quiz e31-2. doi: 10.1016/j.cgh.2013.06.013. Epub 2013 Jun 28. Review.

20.

Hepatic encephalopathy associated with cancer or anticancer therapy.

Willson KJ, Nott LM, Broadbridge VT, Price T.

Gastrointest Cancer Res. 2013 Jan;6(1):11-6.

Supplemental Content

Support Center